August 2023 Price Concessions 1st Update
THIS CONTENT HAS NOW EXPIRED
| Drug | Pack size | Price concession |
| Acamprosate 333mg gastro-resistant tablets | 168 | £23.80 |
| Aciclovir 800mg tablets | 35 | £4.19 |
| Atorvastatin 40mg tablets | 28 | £2.38 |
| Bicalutamide 150mg tablets | 28 | £3.79 |
| Bisacodyl 5mg gastro-resistant tablets | 60 | £4.40 |
| Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops | 5 | £8.19 |
| Brinzolamide 10mg/ml eye drops | 5 | £4.65 |
| Bumetanide 1mg tablets | 28 | £2.77 |
| Buprenorphine 8mg sublingual tablets sugar free | 7 | £4.24 |
| Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment | 30 | £10.09 |
| Carbocisteine 250mg/5ml oral solution | 300 | £6.90 |
| Carvedilol 6.25mg tablets | 28 | £1.39 |
| Clotrimazole 1% cream | 20 | £2.10 |
| Clotrimazole 1% cream | 50 | £3.99 |
| Co-careldopa 25mg/100mg tablets | 100 | £6.95 |
| Codeine 30mg tablets | 28 | £1.08 |
| Codeine 30mg tablets | 100 | £3.85 |
| Doxycycline 100mg capsules | 8 | £0.95 |
| Flecainide 100mg tablets | 60 | £3.85 |
| Flucloxacillin 250mg/5ml oral solution sugar free | 100 | £3.51 |
| Hydroxychloroquine 200mg tablets | 60 | £3.98 |
| Ivabradine 2.5mg tablets | 56 | £45.95 |
| Lamotrigine 100mg tablets | 56 | £2.18 |
| Lansoprazole 15mg orodispersible tablets | 28 | £2.88 |
| Latanoprost 50micrograms/ml eye drops | 2.5 | £1.88 |
| Levetiracetam 100mg/ml oral solution sugar free | 300 | £10.41 |
| Lofepramine 70mg tablets | 56 | £13.51 |
| Mometasone 0.1% ointment | 30 | £4.14 |
| Mycophenolate mofetil 500mg tablets | 50 | £7.30 |
| Oxycodone 5mg/5ml oral solution sugar free | 250 | £9.60 |
| Perindopril erbumine 4mg tablets | 30 | £1.42 |
| Perindopril erbumine 8mg tablets | 30 | £1.64 |
| Pizotifen 1.5mg tablets | 28 | £1.81 |
| Prochlorperazine 5mg tablets | 28 | £1.96 |
| Risperidone 500microgram tablets | 20 | £3.25 |
| Ropinirole 250microgram tablets | 12 | £5.99 |
| Rosuvastatin 10mg tablets | 28 | £1.18 |
| Rosuvastatin 40mg tablets | 28 | £1.70 |
| Spironolactone 100mg tablets | 28 | £4.72 |
| Spironolactone 25mg tablets | 28 | £1.84 |
| Spironolactone 50mg tablets | 28 | £3.99 |
| Tamsulosin 400microgram modified-release capsules | 30 | £1.64 |
| Terbinafine 1% cream | 15 | £3.08 |
| Terbinafine 1% cream | 30 | £6.71 |
| Zopiclone 3.75mg tablets | 28 | £1.83 |
| Zopiclone 7.5mg tablets | 28 | £1.70 |
| The following price concessions rolled over from July to August 2023: | ||
| Cinnarizine 15mg tablets | 84 | £5.47 |
| Co-amoxiclav 250mg/125mg tablets | 21 | £2.69 |
| Co-careldopa 12.5mg/50mg tablets | 90 | £4.56 |
For the full list of price concessions granted so far for August 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.
